Q3 2022 ImpediMed Ltd Activities Report Call Transcript
Thank you for standing by, and welcome to the ImpediMed Limited Quarterly Results and Investor Conference Call. (Operator Instructions)
I would now like to hand the conference over to Mr. Richard Carreon, CEO and Managing Director. Please go ahead.
Thank you, Travis. Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 31 March of 2022. Joining us on the call today is Tim Cruickshank, our Chief Financial Officer; and Mike Bassett, our Senior Vice President of Corporate and Strategic Development. I'll be referencing the 4C when speaking from the quarterly activity report we lodged this morning Australian time. This presentation is a summary of the more detailed 4C. After our remarks, I'll be taking questions.
Let's begin on Page 3. Today, we'll be covering 3 key topics: First, the continued momentum and ongoing strength of our business, even as the health care industry yet
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |